The prevalence of TAZ mutations in our cohort is similar to those from a comprehensive Australian study, which suggested that BTHS may constitute up to 4.8% of boys diagnosed with primary cardiomyopathy [11]. Here, TAFAZZIN is linked to intrinsic cardiomyopathy.